Literature DB >> 20941553

Combination HIV prevention: significance, challenges, and opportunities.

Ann E Kurth1, Connie Celum, Jared M Baeten, Sten H Vermund, Judith N Wasserheit.   

Abstract

No single HIV prevention strategy will be sufficient to control the HIV pandemic. However, a growing number of interventions have shown promise in partially protecting against HIV transmission and acquisition, including knowledge of HIV serostatus, behavioral risk reduction, condoms, male circumcision, needle exchange, treatment of curable sexually transmitted infections, and use of systemic and topical antiretroviral medications by both HIV-infected and uninfected persons. Designing the optimal package of interventions that matches the epidemiologic profile of a target population, delivering that package at the population level, and evaluating safety, acceptability, coverage, and effectiveness, all involve methodological challenges. Nonetheless, there is an unprecedented opportunity to develop "prevention packages" that combine various arrays of evidence-based strategies, tailored to the needs of diverse subgroups and targeted to achieve high coverage for a measurable reduction in population-level HIV transmission. HIV prevention strategies that combine partially effective interventions should be scaled up and evaluated.

Entities:  

Mesh:

Year:  2011        PMID: 20941553      PMCID: PMC3036787          DOI: 10.1007/s11904-010-0063-3

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  61 in total

1.  Sexual partner reductions explain human immunodeficiency virus declines in Uganda: comparative analyses of HIV and behavioural data in Uganda, Kenya, Malawi, and Zambia.

Authors:  Rand L Stoneburner; Daniel Low-Beer
Journal:  Int J Epidemiol       Date:  2004-06-10       Impact factor: 7.196

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda.

Authors:  Rebecca Bunnell; John Paul Ekwaru; Peter Solberg; Nafuna Wamai; Winnie Bikaako-Kajura; Willy Were; Alex Coutinho; Cheryl Liechty; Elizabeth Madraa; George Rutherford; Jonathan Mermin
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

4.  King Kennard Holmes--chair of the Department of Global Health of The University of Washington. Interviewed by Marc Vandenbruaene.

Authors:  King Kennard Holmes
Journal:  Lancet Infect Dis       Date:  2007-08       Impact factor: 25.071

5.  Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy.

Authors:  Michael M Copenhaver; Blair T Johnson; I-Ching Lee; Jennifer J Harman; Michael P Carey
Journal:  J Subst Abuse Treat       Date:  2006-07-13

Review 6.  Effect of treating co-infections on HIV-1 viral load: a systematic review.

Authors:  Kayvon Modjarrad; Sten H Vermund
Journal:  Lancet Infect Dis       Date:  2010-07       Impact factor: 25.071

Review 7.  Effectiveness of condoms in preventing sexually transmitted infections.

Authors:  King K Holmes; Ruth Levine; Marcia Weaver
Journal:  Bull World Health Organ       Date:  2004-06       Impact factor: 9.408

Review 8.  Meta-analytical studies on the epidemiology, prevention, and treatment of human immunodeficiency virus infection.

Authors:  Paschalis I Vergidis; Matthew E Falagas; Davidson H Hamer
Journal:  Infect Dis Clin North Am       Date:  2009-06       Impact factor: 5.982

9.  Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand.

Authors:  Gertrude Khumalo-Sakutukwa; Stephen F Morin; Katherine Fritz; Edwin D Charlebois; Heidi van Rooyen; Alfred Chingono; Precious Modiba; Khalifa Mrumbi; Surasing Visrutaratna; Basant Singh; Michael Sweat; David D Celentano; Thomas J Coates
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

10.  HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe.

Authors:  Elizabeth L Corbett; Beauty Makamure; Yin Bun Cheung; Ethel Dauya; Ronnie Matambo; Tsitsi Bandason; Shungu S Munyati; Peter R Mason; Anthony E Butterworth; Richard J Hayes
Journal:  AIDS       Date:  2007-02-19       Impact factor: 4.177

View more
  134 in total

1.  Operational research to improve HIV prevention in the United States.

Authors:  Jeffrey H Herbst; Marlene Glassman; James W Carey; Thomas M Painter; Deborah J Gelaude; Amy M Fasula; Jerris L Raiford; Arin E Freeman; Camilla Harshbarger; Abigail H Viall; David W Purcell
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

2.  Shifting Resources and Focus to Meet the Goals of the National HIV/AIDS Strategy: The Enhanced Comprehensive HIV Prevention Planning Project, 2010-2013.

Authors:  Stephen A Flores; David W Purcell; Holly H Fisher; Lisa Belcher; James W Carey; Cari Courtenay-Quirk; Erica Dunbar; Agatha N Eke; Carla A Galindo; Marlene Glassman; Andrew D Margolis; Mary Spink Neumann; Cynthia Prather; Dale Stratford; Raekiela D Taylor; Jonathan Mermin
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

3.  Choice in HIV testing: the acceptability and anticipated use of a self-administered at-home oral HIV test among South Africans.

Authors:  Elizabeth A Kelvin; Sonia Cheruvillil; Stephanie Christian; Joanne E Mantell; Cecilia Milford; Letitia Rambally-Greener; Nzwakie Mosery; Ross Greener; Jennifer A Smit
Journal:  Afr J AIDS Res       Date:  2016-07       Impact factor: 1.300

4.  Disparities in HIV Viral Load Suppression by Race/Ethnicity Among Men Who Have Sex with Men in the HIV Outpatient Study.

Authors:  Kate Buchacz; Carl Armon; Ellen Tedaldi; Frank J Palella; Richard M Novak; Douglas Ward; Rachel Hart; Marcus D Durham; John T Brooks
Journal:  AIDS Res Hum Retroviruses       Date:  2018-02-13       Impact factor: 2.205

5.  Evaluating HIV prevention strategies for populations in key affected groups: the example of Cabo Verde.

Authors:  João Filipe G Monteiro; Sandro Galea; Timothy Flanigan; Maria de Lourdes Monteiro; Samuel R Friedman; Brandon D L Marshall
Journal:  Int J Public Health       Date:  2015-04-03       Impact factor: 3.380

6.  Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals?

Authors:  Samuel R Friedman; Brooke S West; Barbara Tempalski; Cory M Morton; Charles M Cleland; Don C Des Jarlais; H Irene Hall; Hannah L F Cooper
Journal:  Ann Epidemiol       Date:  2014-01-24       Impact factor: 3.797

7.  Assessment of changes in risk behaviors during 3 years of posttrial follow-up of male circumcision trial participants uncircumcised at trial closure in Rakai, Uganda.

Authors:  Xiangrong Kong; Godfrey Kigozi; Fred Nalugoda; Richard Musoke; Joseph Kagaayi; Carl Latkin; Robert Ssekubugu; Tom Lutalo; Betty Nantume; Iga Boaz; Maria Wawer; David Serwadda; Ronald Gray
Journal:  Am J Epidemiol       Date:  2012-10-24       Impact factor: 4.897

8.  Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.

Authors:  Carolyne A Akello; Katherine E Bunge; Clemensia Nakabiito; Brenda G Mirembe; Mary Glenn Fowler; Anupam Mishra; Jeanne Marrazzo; Zvavahera M Chirenje; Connie Celum; Jennifer E Balkus
Journal:  J Womens Health (Larchmt)       Date:  2017-02-17       Impact factor: 2.681

Review 9.  Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects.

Authors:  Larry W Chang; David Serwadda; Thomas C Quinn; Maria J Wawer; Ronald H Gray; Steven J Reynolds
Journal:  Lancet Infect Dis       Date:  2013-01       Impact factor: 25.071

10.  Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

Authors:  Elisa F Long; Robert R Stavert
Journal:  J Gen Intern Med       Date:  2013-04-16       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.